Elena A Lukina (Elena Lukina, E A Lukina)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 8

Top Topics

Iron Deficiency

Top Venues

Terapevticheskii arkhiv

American journal of hematology

Annals of hematology

This page only lists publications with an associated author ORCID identifier.

Publications

M A Mozdon, R V Ponomarev, N V Tsvetaeva, A V Shabrin, E I Ermachenkova, S E Larichev, Elena A Lukina
[Iron deficiency anemia in a patient with hereditary hemorrhagic telangiectasia. Case report]. Terapevticheskii arkhiv 95 (7) (2023)
M A Mozdon, R V Ponomarev, N V Tsvetaeva, A V Shabrin, E I Ermachenkova, S E Larichev, Elena A Lukina
[Iron deficiency anemia in a patient with hereditary hemorrhagic telangiectasia. Case report]. Terapevticheskii arkhiv 95 (7) (2023)
V D Latyshev, Elena A Mershina, I E Kostina, Valentin E Sinitsyn, Elena A Lukina
[Erdheim-Chester disease with cardiac involvement. Case report]. Terapevticheskii arkhiv 94 (7) (2022)
Pramod K Mistry, Elena A Lukina, Hadhami Ben Turkia, Suma P Shankar, Hagit Baris Feldman, Marwan Ghosn, Atul Mehta, Seymour Packman, Heather Lau, Milan Petakov, Sarit Assouline, Manisha Balwani, Sumita Danda, Evgueniy Hadjiev, Andres Ortega, Meredith C Foster, Sebastiaan J M Gaemers, M Judith Peterschmitt
Clinical outcomes after 4.5 years of eliglustat therapy for Gaucher disease type 1: Phase 3 ENGAGE trial final results. American journal of hematology 96 (9) (2021)
Alexander Dmitrievich Kulagin, Vadim V Ptushkin, Elena A Lukina, Igor L Davydkin, Alexander V Korobkin, Vladimir S Shamrai, Tatyana S Konstantinova, Tatyana S Kaporskaya, Tatyana A Mitina, Tatyana I Ksenzova, Evgeny V Zuev, Oksana A Markova, Elena V Gapchenko, Dmitry Anatolievich Kudlay
Randomized multicenter noninferiority phase III clinical trial of the first biosimilar of eculizumab. Annals of hematology 100 (11) (2021)
R V Ponomarev, Elena A Lukina
[Gaucher disease: achievements and prospects]. Terapevticheskii arkhiv 93 (7) (2021)
Vadim V Ptushkin, Alexander Dmitrievich Kulagin, Elena A Lukina, Igor L Davydkin, Tatyana S Konstantinova, Vladimir S Shamrai, N V Minaeva, Dmitry Anatolievich Kudlay, Elena V Gapchenko, Oksana A Markova, A Y Borozinets
[Results of phase Ib open multicenter clinical trial of the safety, pharmacokinetics and pharmacodynamics of first biosimilar of eculizumab in untreated patients with paroxysmal nocturnal hemoglobinuria during induction of therapy]. Terapevticheskii arkhiv 92 (7) (2020)
Elena A Lukina, Nora Watman, Marta Dragosky, Heather Lau, Elsa Avila Arreguin, Hanna Rosenbaum, Ari Zimran, Meredith C Foster, Sebastiaan J M Gaemers, M Judith Peterschmitt
Outcomes after 8 years of eliglustat therapy for Gaucher disease type 1: Final results from the Phase 2 trial. American journal of hematology 94 (1) (2018)